STAAR Surgical Company (STAA) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$27.75
Price Target
$22.95
Target Range
$13.00 — $30.75
Analyst Rating
Hold
Forward P/E71.4x
Trailing P/E-17.1x
Forward PEG—
Implied Growth+124.0%
Median Target$26.00
Analyst Spread77.3%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$13
-53.2%
Consensus
$23
-17.3%
Bull Case
$31
+10.8%
STAA Price Target Analysis
Updated May 7, 2026As of May 7, 2026, STAAR Surgical Company (STAA) has a Wall Street consensus price target of $22.95, based on estimates from 15 covering analysts. With the stock currently trading at $27.75, this represents a potential downside of -17.3%. The company has a market capitalization of $1.37B.
Analyst price targets range from a low of $13.00 to a high of $30.75, representing a 77% spread in expectations. The median target of $26.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 3 analysts rating the stock as a Buy or Strong Buy,11 rating it Hold, and 1 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, STAA trades at a trailing P/E of -17.1x and forward P/E of 71.4x. Analysts expect EPS to grow +124.0% over the next year.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+51.4%
Avg Forward P/E64.1x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ALGNAlign Technology, Inc. | $12.5B | $173.94 | $203.60 | +17.1% | Buy | 15.3x | 33 |
 LNTHLantheus Holdings, Inc. | $5.6B | $86.15 | $101.00 | +17.2% | Buy | 16.6x | 17 |
 TMDXTransMedics Group, Inc. | $2.5B | $72.92 | $144.75 | +98.5% | Buy | 29.9x | 12 |
 EWEdwards Lifesciences Corporation | $48.0B | $83.20 | $96.53 | +16.0% | Buy | 27.7x | 48 |
 HOLXHologic, Inc. | $17.0B | $76.01 | $79.00 | +3.9% | Hold | 17.2x | 42 |
 ATRCAtriCure, Inc. | $1.4B | $28.01 | $50.67 | +80.9% | Buy | 373.5x | 19 |
 NVCRNovoCure Limited | $1.9B | $16.50 | $33.50 | +103.1% | Buy | — | 15 |
 IRTCiRhythm Technologies, Inc. | $3.9B | $117.70 | $193.67 | +64.5% | Buy | — | 19 |
 ABTAbbott Laboratories | $150.0B | $86.25 | $128.71 | +49.2% | Buy | 15.7x | 41 |
 BSXBoston Scientific Corporation | $83.2B | $56.00 | $91.33 | +63.1% | Buy | 16.6x | 43 |
Upside Potential Comparison
NVCRTMDXATRCIRTCBSXABTLNTHALGNSee STAA's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs STAA Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare STAA vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSTAA — Frequently Asked Questions
Quick answers to the most common questions about buying STAA stock.
What is the STAA stock price target for 2026?
STAA's consensus price target is $22.95, -17.3% below the current price of $27.75. The 15 analysts tracking STAA see downside risk at present valuations.
Is STAA a buy, sell, or hold?
STAA has a consensus rating of "Hold" based on 15 Wall Street analysts. The rating breakdown is mixed, with 11 Hold ratings making up the largest segment. The consensus 12-month price target of $22.95 implies -17.3% downside from current levels.
Is STAA stock overvalued or undervalued?
At a forward P/E of 71.3735x, STAA trades at a premium valuation. The consensus price target of $22.95 (-17.3% downside) suggests analysts may view current valuations as stretched.
How high can STAA stock go?
The most bullish Wall Street analyst has a price target of $30.75 for STAA, while the most conservative target is $13. The consensus of $22.95 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover STAA stock?
STAA is well covered by analysts, with 15 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 3 have Buy ratings, 11 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the STAA stock forecast?
The 12-month STAA stock forecast based on 15 Wall Street analysts shows a consensus price target of $22.95, with estimates ranging from $13 (bear case) to $30.75 (bull case). The median consensus rating is "Hold".
What is STAA's forward P/E ratio?
STAA trades at a forward P/E ratio of 71.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy STAA stock?
Analysts are cautious on STAA, with 1 Sell ratings and a price target of $22.95 (-17.3% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do STAA price targets vary so much?
STAA analyst price targets range from $13 to $30.75, a 77% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $22.95 consensus represents the middle ground.